부산대학교 도서관

Manivannan M; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Jehanno C; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Kloc M; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.; Gomez Miragaya J; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Diepenbruck M; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Volkmann K; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Coissieux MM; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Palafox M; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Rouchon A; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Kramer N; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Schmidt A; Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland.; Blum Y; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Hamelin B; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Schuster H; Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland.; Heidinger M; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Breast Center, University Hospital Basel, University of Basel, Basel, Switzerland.; Muenst S; Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland.; Vetter M; Cancer Centre Baselland, Medical University Clinic, Cantonal Hospital Baselland, Liestal, Switzerland.; Medical Faculty, University of Basel, Basel, Switzerland.; Kurzeder C; Department of Gynecology, University Hospital Basel, University of Basel, Basel, Switzerland.; Weber WP; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Breast Center, University Hospital Basel, University of Basel, Basel, Switzerland.; Bentires-Alj M; Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland. m.bentires-alj@unibas.ch.; Department of Surgery, University Hospital Basel, Basel, Switzerland. m.bentires-alj@unibas.ch.

Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Ciscar, Marina; Trinidad, Eva M; Perez-Chacon, Gema; Alsaleem, Mansour; Jimenez, Maria; Jimenez-Santos, Maria J; Perez-Montoyo, Hector; Sanz-Moreno, Adrian; Vethencourt, Andrea; Toss, Michael; Petit, Anna; Soler-Monso, Maria T; Lopez, Victor; Gomez-Miragaya, Jorge; Gomez-Aleza, Clara; Dobrolecki, Lacey E; Lewis, Michael T; Bruna, Alejandra; Mouron, Silvana; Al-Shahrour, Fatima; Quintela Fandino, Miguel Angel; Martinez-Aranda, Antonio; Sierra, Angels; Green, Andrew R; Rakha, Emad; Gonzalez-Suarez, Eva

Repisalud
Instituto de Salud Carlos III (ISCIII)

Marina Ciscar; Eva M Trinidad; Gema Perez‐Chacon; Mansour Alsaleem; Maria Jimenez; Maria J Jimenez‐Santos; Hector Perez‐Montoyo; Adrian Sanz‐Moreno; Andrea Vethencourt; Michael Toss; Anna Petit; Maria T Soler‐Monso; Victor Lopez; Jorge Gomez‐Miragaya; Clara Gomez‐Aleza; Lacey E Dobrolecki; Michael T Lewis; Alejandra Bruna; Silvana Mouron; Miguel Quintela‐Fandino; Fatima Al‐Shahrour; Antonio Martinez‐Aranda; Angels Sierra; Andrew R Green; Emad Rakha; Eva Gonzalez‐Suarez

EMBO Molecular Medicine, Vol 15, Iss 4, Pp 1-12 (2023)

Gomes I; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Martelo M; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Vilela RD; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Jiménez M; Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Trinidad EM; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Gómez-Miragaya J; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; González-Suárez E; Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Martins É; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Torres SS; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; Corredeira P; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Miranda JL; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Mansinho A; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; START Lisbon, Local Health Unit of Santa Maria, Lisbon, Portugal.; Torres S; Oncology Division, Local Health Unit of Santa Maria, Lisbon, Portugal.; Abreu C; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; Oncology Division, Local Health Unit of Santa Maria, Lisbon, Portugal.; Sousa R; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; Oncology Division, Local Health Unit of Santa Maria, Lisbon, Portugal.; Casimiro S; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; Costa L; Oncology Translational Laboratory, GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; Oncology Division, Local Health Unit of Santa Maria, Lisbon, Portugal.

Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

Mateo, F; Arenas, EJ; Aguilar, H; Serra-Musach, J; de Garibay, G Ruiz; Boni, J; Maicas, M; Du, S; Iorio, F; Herranz-Ors, C; Islam, A; Prado, X; Llorente, A; Petit, A; Vidal, A; Català, I; Soler, T; Venturas, G; Rojo-Sebastian, A; Serra, H; Cuadras, D; Blanco, I; Lozano, J; Canals, F; Sieuwerts, AM; de Weerd, V; Look, MP; Puertas, S; García, N; Perkins, AS; Bonifaci, N; Skowron, M; Gómez-Baldó, L; Hernández, V; Martínez-Aranda, A; Martínez-Iniesta, M; Serrat, X; Cerón, J; Brunet, J; Barretina, MP; Gil, M; Falo, C; Fernández, A; Morilla, I; Pernas, S; Plà, MJ; Andreu, X; Seguí, MA; Ballester, R; Castellà, E; Nellist, M; Morales, S; Valls, J; Velasco, A; Matias-Guiu, X; Figueras, A; Sánchez-Mut, JV; Sánchez-Céspedes, M; Cordero, A; Gómez-Miragaya, J; Palomero, L; Gómez, A; Gajewski, TF; Cohen, EEW; Jesiotr, M; Bodnar, L; Quintela-Fandino, M; López-Bigas, N; Valdés-Mas, R; Puente, XS; Viñals, F; Casanovas, O; Graupera, M; Hernández-Losa, J; Ramón y Cajal, S; García-Alonso, L; Saez-Rodriguez, J; Esteller, M; Sierra, A; Martín-Martín, N; Matheu, A; Carracedo, A; González-Suárez, E; Nanjundan, M; Cortés, J; Lázaro, C; Odero, MD; Martens, JWM; Moreno-Bueno, G; Barcellos-Hoff, MH; Villanueva, A; Gomis, RR; Pujana, MA

Oncogene
Recercat. Dipósit de la Recerca de Catalunya
instname
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
RUO: Repositorio Institucional de la Universidad de Oviedo
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
RIUVic. Repositorio Institucional de la Universidad de Vic
RiUVic. Repositori institucional de la UVic-UCC
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Oncogene, vol 36, iss 19
Oncogene : including Oncogene reviews 36(19), 2737-2749 (2017). doi:10.1038/onc.2016.427

Couto JP; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Vulin M; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Jehanno C; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Coissieux MM; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Hamelin B; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Schmidt A; Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland.; Ivanek R; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.; Sethi A; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.; Bräutigam K; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.; Institute of Pathology, University of Bern, Bern, Switzerland.; Frei AL; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.; Hager C; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Manivannan M; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Gómez-Miragaya J; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Obradović MM; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Varga Z; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.; Koelzer VH; Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.; Mertz KD; Institute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.; Bentires-Alj M; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Surgery, University Hospital Basel, Basel, Switzerland.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

Piqué, Laia; Martinez de Paz, A.; Piñeyro, David; Martínez Cardús, Anna; Castro de Moura, Manuel; Llinàs-Arias, Pere; Setien, F.; Gómez-Miragaya, Jorge; González-Suárez, Eva; Sigurdsson, S.; Jonasson, J. G.; Villanueva, Alberto; Vidal, A.; Davalos, Veronica; Esteller, M.; Universitat Autònoma de Barcelona

Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Mateo, Francesca; Arenas, Enrique J; Aguilar, Helena; Serra-Musach, Jordi; Ruiz de Garibay, Gorka; Boni, Jacopo; Maicas, Miren; Du, Shisuo; Iorio, Francesco; Herranz-Ors, Carmen; Islam, Abul; Prado, X.; Llorente, Alicia; Petit Montserrat, Anna; Vidal, August; Català, Isabel; Soler, Teresa; Venturas, G.; Rojo-Sebastian, Alejandro; Serra, Helena; Cuadras, Daniel; Blanco Guillermo, Ignacio; Lozano, José; Canals, Francesc; Sieuwerts, Anieta M.; De Weerd, Vanja; Look, Maxime P.; Puertas, Sara; García, Nadia; Perkins, Archibald S.; Bonifaci, Núria; Skowron, Margaretha A.; Gómez-Baldó, Laia; Hernández, Vanessa; Martínez-Aranda, Antonio; Martínez-Iniesta, Maria; Serrat Farran, Xènia; Cerón, Julián; Brunet, Joan; Barretina-Ginesta, Maria-Pilar; Gil, Mercedes; Falo, Catalina; Fernández, Adela; Morilla, Idoia; Pernas, Sonia; Plà, Maria Jesus; Andreu, Xavier; Segui Palmer, Miquel Angel; Ballester, Rosa; Castellà Fernández, Eva; Nellist, Mark D.; Morales, Saleta; Valls, Joan; Velasco, Ana; Matías-Guiu, Xavier; Figueras, Agnes; Sánchez-Mut, José Vicente; Sanchez-Cespedes, Montse; Cordero Casanovas, Alex; Gómez-Miragaya, Jorge; Palomero, Luis; Gómez-Caamaño, Antonio; Gajewski, Thomas F.; Cohen, Ezra E. W.; Jesiotr, Marzena; Bodnar, Lubomir; Quintela-Fandino, Miguel; Lopez-Bigas, Nuria; Valdés-Mas, Rafael; Puente, Xose S.; Viñals, Francesc; Casanovas, Oriol; Graupera, Mariona; Hernandez-Losa, Javier; Ramón y Cajal, Santiago; Garcia-Alonso, Luz; Saez-Rodriguez, J.; Esteller, M; Sierra-Jimenez, Angels; Martín-Martín, Natalia; Matheu Fernandez, Ander; Carracedo, Arkaitz; González-Suárez, Eva; Nanjundan, Meera; Cortés Castán, Javier; Lazaro Garcia, Conxi; Odero, Maria D.; Martens, John W. M.; Moreno-Bueno, Gema; Barcellos-Hoff, Mary Helen; Villanueva, Alberto; Gomis, Roger R..; Genestar Pujana, Miguel Ángel; Universitat Autònoma de Barcelona

Sanz-Moreno A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Present Address: German Mouse Clinic, Institute of Experimental Genetics, HMGU, Neuherberg, 85764, Germany.; Palomeras S; New Therapeutics Targets Lab (TargetsLab), Department of Medical Sciences, University of Girona, Girona, Spain.; Pedersen K; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Morancho B; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pascual T; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Benítez S; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Gomez-Miragaya J; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Present Address: Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.; Ciscar M; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Jimenez M; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Pernas S; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Petit A; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain.; Soler-Monsó MT; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain.; Viñas G; New Therapeutics Targets Lab (TargetsLab), Department of Medical Sciences, University of Girona, Girona, Spain.; Medical Oncology Department, Catalan Institute of Oncology (ICO), Girona, Spain.; Alsaleem M; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.; Rakha EA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.; Green AR; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.; Santamaria PG; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Mulder C; Biomolecular Mass Spectrometry and Proteomics Bijvoet Center, Utrecht University, Utrecht, The Netherlands.; Lemeer S; Biomolecular Mass Spectrometry and Proteomics Bijvoet Center, Utrecht University, Utrecht, The Netherlands.; Arribas J; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Puig T; New Therapeutics Targets Lab (TargetsLab), Department of Medical Sciences, University of Girona, Girona, Spain. teresa.puig@udg.edu.; Gonzalez-Suarez E; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. egsuarez@idibell.cat.; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. egsuarez@idibell.cat.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Gómez-Miragaya J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain.; Díaz-Navarro A; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), CIBERONC, Universidad de Oviedo, Oviedo, Spain.; Tonda R; CNAG-CRG, Centre for Genomic Regulation (CRG), Institute of Science and Technology (BIST), Centre for Genomic Analysis (CNAG), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Beltran S; CNAG-CRG, Centre for Genomic Regulation (CRG), Institute of Science and Technology (BIST), Centre for Genomic Analysis (CNAG), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Palomero L; Breast Cancer and Systems Biology Laboratory, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Palafox M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain.; Dobrolecki LE; Departments of Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Huang C; Departments of Molecular and Human Genetics, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Vasaikar S; Departments of Molecular and Human Genetics, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Zhang B; Departments of Molecular and Human Genetics, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Wulf GM; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Collado-Sole A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain.; Trinidad EM; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain.; Muñoz P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain.; Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; Bruna A; Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Caldas C; Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Arribas J; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Soler-Monso MT; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain.; Petit A; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain.; Balmaña J; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Cruz C; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Serra V; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Pujana MA; Breast Cancer and Systems Biology Laboratory, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Lewis MT; Departments of Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Puente XS; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), CIBERONC, Universidad de Oviedo, Oviedo, Spain.; González-Suárez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain. egsuarez@idibell.cat.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Blancafort A; New Therapeutic Targets Lab (TargetsLab), Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.; Giró-Perafita A; New Therapeutic Targets Lab (TargetsLab), Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.; Oliveras G; New Therapeutic Targets Lab (TargetsLab), Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain; Catalan Institute of Oncology, Hospital Dr. Josep Trueta, Girona, Spain.; Palomeras S; New Therapeutic Targets Lab (TargetsLab), Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.; Turrado C; Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.; Campuzano Ò; Cardiovascular Genetics Center, University of Girona-IDIBGi, Girona, Spain.; Carrión-Salip D; Biochemistry and Molecular Biology Unit, Department of Biology, University of Girona, Girona, Spain.; Massaguer A; Biochemistry and Molecular Biology Unit, Department of Biology, University of Girona, Girona, Spain.; Brugada R; Cardiovascular Genetics Center, University of Girona-IDIBGi, Girona, Spain.; Palafox M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), Hospitalet de Llobregat-Barcelona, Spain.; Gómez-Miragaya J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), Hospitalet de Llobregat-Barcelona, Spain.; González-Suárez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), Hospitalet de Llobregat-Barcelona, Spain.; Puig T; New Therapeutic Targets Lab (TargetsLab), Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Piqué L; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Martinez de Paz A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Piñeyro D; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Martínez-Cardús A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Castro de Moura M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Llinàs-Arias P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Setien F; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Gomez-Miragaya J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Gonzalez-Suarez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Sigurdsson S; Department of Biochemistry and Molecular Biology, Biomedical Center, Vatnsmyrarvegur 16, 101, Reykjavik, Iceland.; Jonasson JG; Faculty of Medicine, University of Iceland, Sturlugata 8, 101, Reykjavik, Iceland.; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.; Villanueva A; Translational Research Laboratory, IDIBELL-Institut Catala d'Oncologia, Barcelona, Catalonia, Spain.; Vidal A; Department of Pathology, Bellvitge University Hospital, Barcelona, Catalonia, Spain.; Davalos V; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain. mesteller@carrerasresearch.org.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

Gómez-Miragaya J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Morán S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Calleja-Cervantes ME; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Collado-Sole A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Gómez A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Serra V; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Dobrolecki LE; Departments of Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Lewis MT; Departments of Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Diaz-Lagares A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), CIBERONC, Santiago de Compostela, Spain.; Eroles P; Biomedical Research Institute (INCLIVA), Valencia, Spain. CIBERONC, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; González-Suárez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. egsuarez@idibell.cat.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

Yoldi G; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Pellegrini P; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Trinidad EM; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Cordero A; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Gomez-Miragaya J; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Serra-Musach J; Program Against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology Lab, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.; Dougall WC; Therapeutic Innovation Unit, Amgen Inc., Seattle, Washington.; Muñoz P; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Pujana MA; Program Against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology Lab, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.; Planelles L; Centro Nacional de Biotecnología/CSIC, UAM Cantoblanco, Madrid, Spain.; González-Suárez E; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain. egsuarez@idibell.cat.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Gomez-Miragaya J; Transformation and Metastasis laboratory, Cancer Epigenetics and Biology Program (PEBC), Biomedical Research Institute of Bellvitge (IDIBELL), Barcelona, Spain, Av.Gran Via de L'Hospitalet, 199 - 203. L'Hospitalet de Llobregat, Barcelona, Spain.; González-Suárez E; Transformation and Metastasis laboratory, Cancer Epigenetics and Biology Program (PEBC), Biomedical Research Institute of Bellvitge (IDIBELL), Barcelona, Spain, Av.Gran Via de L'Hospitalet, 199 - 203. L'Hospitalet de Llobregat, Barcelona, Spain.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101642411 Publication Model: eCollection Cited Medium: Print ISSN: 2372-3556 (Print) Linking ISSN: 23723556 NLM ISO Abbreviation: Mol Cell Oncol Subsets: PubMed not MEDLINE

Gómez-Miragaya J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Palafox M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.; Yoldi G; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Ferrer I; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Vila S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.; Pellegrini P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Pérez-Montoyo H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Igea A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.; Muñoz P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain; Unitat de Bioquímica i Biologia Molecular, Departament de Ciències Fisiològiques II, Universitat de Barcelona-IDIBELL, 08908 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, 08010 Barcelona, Spain.; Nebreda AR; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, 08010 Barcelona, Spain.; Urruticoechea A; Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.; Morilla I; Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.; Pernas S; Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.; Climent F; Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain.; Soler-Monso MT; Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain.; Petit A; Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.; González-Suárez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain. Electronic address: egsuarez@idibell.cat.

Publisher: Cell Press Country of Publication: United States NLM ID: 101611300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-6711 (Electronic) Linking ISSN: 22136711 NLM ISO Abbreviation: Stem Cell Reports Subsets: MEDLINE

Sanz-Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomas; Galván, Patricia; Benítez, Sandra; Gomez-Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sonia; Petit, Anna; Soler-Monsó, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Celine Mulder; Lemeer, Simone; Joaquin Arribas; Aleix Prat; Puig, Teresa; Gonzalez-Suarez, Eva

Sanz-Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomas; Galván, Patricia; Benítez, Sandra; Gomez-Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sonia; Petit, Anna; Soler-Monsó, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Celine Mulder; Lemeer, Simone; Joaquin Arribas; Aleix Prat; Puig, Teresa; Gonzalez-Suarez, Eva